Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06005129 · ClinicalTrials.gov registry record · NA

Personality Change Study for Borderline Personality Disorder

A NA study of Borderline Personality Disorder, sponsored by Shannon E. Sauer-Zavala.

Active
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT06005129 is a NA study of Borderline Personality Disorder that is active but no longer recruiting, run by Shannon E. Sauer-Zavala. The registered enrollment target is 30 participants, below the 106-participant average among 16 other Borderline Personality Disorder trials with a reported enrollment target (72% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06005129, a NA study of Borderline Personality Disorder, is active but no longer recruiting, sponsored by Shannon E. Sauer-Zavala.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

Participants with borderline personality disorder will undergo an a 2 - 4 week baseline assessment to determine level of outcomes of interest in the absence of treatment. After the baseline period, participants will receive six weekly 50-60-minute treatment sessions. After the 6 treatment sessions, participants will complete a 4-week follow-up period to determine the sustainability of the treatment module.

Interventions

  • BEHAVIORAL Personality-Based Therapy

Study Locations (1)

Kentucky

  • Clinic for Emotional Health at the University of Kentucky - Lexington

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2024-09-15
Est. Completion 2026-03-31
Phase NA

Sponsor

Shannon E. Sauer-Zavala

5 total trials

What the Registry Record Tells You About NCT06005129

The ClinicalTrials.gov registry entry for NCT06005129 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 106-participant average among 16 other Borderline Personality Disorder trials with a reported enrollment target (72% lower). The listed sponsor is Shannon E. Sauer-Zavala, which has 5 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Borderline Personality Disorder appearing as the primary indexed condition, and to 1 intervention - of which Personality-Based Therapy is the first listed.

NCT06005129 reports 1 study location spanning 1 distinct geographic area - top geographies include Kentucky.

Frequently Asked Questions

What is clinical trial NCT06005129 about?

NCT06005129 is a clinical study titled "Personality Change Study for Borderline Personality Disorder". Participants with borderline personality disorder will undergo an a 2 - 4 week baseline assessment to determine level of outcomes of interest in the absence of treatment. After the baseline period, participants will receive six weekly 50-60-minute treatment sessions. After the 6 treatment sessions, ...

What is the current status of trial NCT06005129?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2024-09-15. Estimated completion is 2026-03-31.

What conditions does trial NCT06005129 study?

This clinical trial studies the following conditions: Borderline Personality Disorder.

What interventions are being tested in trial NCT06005129?

The interventions under investigation include: Personality-Based Therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT06005129?

This trial is sponsored by Shannon E. Sauer-Zavala, which has 5 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06005129 being conducted?

This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Borderline Personality Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.